Literature DB >> 14715715

Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice.

Sudha Srinivasan1, Donna O Bunch, Yun Feng, Ramona M Rodriguiz, Min Li, Roneka L Ravenell, Guo X Luo, Akira Arimura, Lloyd D Fricker, Edward M Eddy, William C Wetsel.   

Abstract

Cpe(fat/fat) mice are obese, diabetic, and infertile. These animals have a point mutation in carboxypeptidase E (CPE), an exopeptidase that removes C-terminal basic amino acids from peptide intermediates. The mutation renders the enzyme unstable, and it is rapidly degraded. Although the infertility of Cpe(fat/fat) mice has not been systematically investigated, it is thought to be due to a deficit in GnRH processing. We have evaluated this hypothesis and found hypothalamic GnRH levels to be reduced by 65-78% and concentrations of pro-GnRH and C-terminal-extended intermediates to be high. Basal serum gonadotropin contents are similar among wild-type, heterozygous, and homozygous mice. Testis morphology and function are abnormal in older obese Cpe(fat/fat) mice. Matings between homozygous mutants yield a 5% pregnancy rate. By comparison, when 50-d-old Cpe(fat/fat) males are paired with heterozygous females, rates increase to 43%, and they rapidly decrease to negligible levels by 120 d. As fertility declines without accompanying changes in the hypothalamic-pituitary-gonadal axis and before obesity is evident, reproduction is more complex than originally thought. This suspicion is confirmed in 90-d-old Cpe(fat/fat) males, who readily interact with females, but rarely mount and fail to show intromission or ejaculation behaviors. Together, these findings show that CPE is a key enzyme for pro-GnRH processing in vivo; however, the reproductive deficits in Cpe(fat/fat) males appear to be due primarily to abnormal sexual behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715715     DOI: 10.1210/en.2003-1442

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

Review 2.  Neuropeptide-processing enzymes: applications for drug discovery.

Authors:  Lloyd D Fricker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

3.  An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.

Authors:  Terence K Lee; Saravana R K Murthy; Niamh X Cawley; Savita Dhanvantari; Stephen M Hewitt; Hong Lou; Tracy Lau; Stephanie Ma; Thanh Huynh; Robert A Wesley; Irene O Ng; Karel Pacak; Ronnie T Poon; Y Peng Loh
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

4.  Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity.

Authors:  Latrice D Faulkner; Abigail R Dowling; Ronald C Stuart; Eduardo A Nillni; Jennifer W Hill
Journal:  Endocrinology       Date:  2015-01-15       Impact factor: 4.736

5.  Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.

Authors:  Saravana R K Murthy; Karel Pacak; Y Peng Loh
Journal:  Cell Mol Neurobiol       Date:  2010-11       Impact factor: 5.046

6.  Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.

Authors:  Ramona M Rodriguiz; John J Wilkins; Thomas K Creson; Reeta Biswas; Iryna Berezniuk; Arun D Fricker; Lloyd D Fricker; William C Wetsel
Journal:  Int J Neuropsychopharmacol       Date:  2013-02-27       Impact factor: 5.176

7.  Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing.

Authors:  Xin Zhang; Fa-Yun Che; Iryna Berezniuk; Kemal Sonmez; Lawrence Toll; Lloyd D Fricker
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

Review 8.  Carboxypeptidases in disease: insights from peptidomic studies.

Authors:  Matthew R Sapio; Lloyd D Fricker
Journal:  Proteomics Clin Appl       Date:  2014-03-24       Impact factor: 3.494

Review 9.  60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides.

Authors:  Niamh X Cawley; Zhaojin Li; Y Peng Loh
Journal:  J Mol Endocrinol       Date:  2016-02-15       Impact factor: 5.098

Review 10.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.